Royalty Pharma (RPRX) Shares Repurchased (2019 - 2025)
Historic Shares Repurchased for Royalty Pharma (RPRX) over the last 4 years, with Q3 2025 value amounting to $146.5 million.
- Royalty Pharma's Shares Repurchased rose 5095.37% to $146.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 47876.37%. This contributed to the annual value of $229.7 million for FY2024, which is 2464.5% down from last year.
- Per Royalty Pharma's latest filing, its Shares Repurchased stood at $146.5 million for Q3 2025, which was up 5095.37% from $291.6 million recorded in Q2 2025.
- Royalty Pharma's 5-year Shares Repurchased high stood at $708.8 million for Q1 2025, and its period low was $30.2 million during Q4 2023.
- Its 3-year average for Shares Repurchased is $193.4 million, with a median of $118.6 million in 2023.
- Per our database at Business Quant, Royalty Pharma's Shares Repurchased crashed by 3074.0% in 2024 and then skyrocketed by 26446.96% in 2025.
- Quarter analysis of 3 years shows Royalty Pharma's Shares Repurchased stood at $30.2 million in 2023, then soared by 74.2% to $52.6 million in 2024, then skyrocketed by 178.47% to $146.5 million in 2025.
- Its last three reported values are $146.5 million in Q3 2025, $291.6 million for Q2 2025, and $708.8 million during Q1 2025.